Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study
Titel:
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study
Auteur:
Douillard, J.-Y. Gervais, R. Dabouis, G. Le Groumellec, A. D'Arlhac, M. Spaeth, D. Coudert, B. Caillaud, D. Monnier, A. Clary, C. Maury, B. Mornet, M. Rivière, A. Clouet, P. Couteau, C.